An intracellular multi-effector complex mediates somatostatin receptor 1 activation of phospho-tyrosine phosphatase η

Molecular Endocrinology

Volumn 21, Issue 1, 2007, Pages 229-246

  Arena, Sara ^a   Pattarozzi, Alessandra ^a   Massa, Alessandro ^a   Esteve, Jean Pierre ^b   Iuliano, Rodolfo ^c   Fusco, Alfredo ^d   Susini, Christiane ^b   Florio, Tullio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b INSERM   (France)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTERASE; GUANINE NUCLEOTIDE BINDING PROTEIN; JANUS KINASE 2; PERTUSSIS TOXIN; PHOSPHOTYROSINE PHOSPHATASE ETA; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 2; SOMATOSTATIN RECEPTOR 1; STEROID RECEPTOR COACTIVATOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHINESE HAMSTER; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; CYTOSOL; ENZYME ACTIVATION; GENES, DOMINANT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JANUS KINASE 2; PERTUSSIS TOXIN; PROTEIN BINDING; PROTEIN-TYROSINE-PHOSPHATASE; RATS; RECEPTORS, SOMATOSTATIN; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

CRICETULUS GRISEUS;

EID: 33845969497     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2006-0081     Document Type: Article

References (76)

1. Florio T, Pan MG, Newman B, Hershberger RE, Civelli O, Stork PJ 1992 Dopaminergic inhibition of DNA synthesis in pituitary tumor cells is associated with phosphotyrosine phosphatase activity. J Biol Chem 267:24169-24172
2. Lee MT, Liebow C, Kamer AR, Schally AV 1991 Effects of epidermal growth factor, analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors. Proc Natl Acad Sci USA 88:1656-1660
3. Imai A, Takagi H, Furui T, Horibe S, Fuseya T, Tamaya T 1996 Evidence for coupling of phosphotyrosine phosphatase to gonadotropin-releasing hormone receptor in ovarian carcinoma membrane. Cancer 77:132-137
4. Pan MG, Florio T, Stork PJ 1992 G protein activation of a hormone-stimulated phosphatase in human tumor cells. Science 256:1215-1217
5. Colas B, Cambillau C, Buscail L, Zeggari M, Esteve JP, Lautre V, Thomas F, Vaysse N, Susini C 1992 Stimulation of a membrane tyrosine phosphatase activity by somatostatin analogues in rat pancreatic acinar cells. Eur J Biochem 207:1017-1024
6. Florio T, Scorziello A, Fattore M, D'Alto V, Salzano S, Rossi G, Berlingieri MT, Fusco A, Schettini G 1996 Somatostatin inhibits PC Cl3 thyroid cell proliferation through the modulation of phosphotyrosine activity. Impairment of the somatostatinergic effects by stable expression of E1A viral oncogene. J Biol Chem 271:6129-6136
7. Lopez F, Esteve JP, Buscail L, Delesque N, Saint-Laurent N, Vaysse N, Susini C 1996 Molecular mechanisms of antiproliferative effect of somatostatin: involvement of a tyrosine phosphatase. Metabolism 45:14-16
8. Reardon DB, Dent P, Wood SL, Kong T, Sturgill TW 1997 Activation in vitro of somatostatin receptor subtypes 2, 3, or 4 stimulates protein tyrosine phosphatase activity in membranes from transfected Ras-transformed NIH 3T3 cells: coexpression with catalytically inactive SHP-2 blocks responsiveness. Mol Endocrinol 11:1062-1069
9. Patel YC 1999 Somatostatin and its receptor family. Front Neuroendocrinol 20:157-198
10. Schulz S, Handel M, Schreff M, Schmidt H, Hollt V 2000 Localization of five somatostatin receptors in the rat central nervous system using subtype-specific antibodies. J Physiol Paris 94:259-264
11. de Herder WW, Hofland LJ, van der Lely AJ, Lamberts SW 2003 Somatostatin receptors in gastroentero-pancreatic neuroendocrine tumours. Endocr Relat Cancer 10:451-458
12. Reubi JC, Laissue JA 1995 Multiple actions of somatostatin in neoplastic disease. Trends Pharmacol Sci 16:110-115
13. Albini A, Florio T, Giunciuglio D, Masiello L, Carlone S, Corsaro A, Thellung S, Cai T, Noonan DM, Schettini G 1999 Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis. FASEB J 13:647-655
14. Florio T, Morini M, Villa V, Arena S, Corsaro A, Thellung S, Culler MD, Pfeffer U, Noonan DM, Schettini G, Albini A 2003 Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activities. Endocrinology 144:1574-1584
15. Weckbecker G, Lewis I, Albert R, Schmid HA, Hoyer D, Bruns C 2003 Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat Rev Drug Discov 2:999-1017
16. Florio T, Rim C, Hershberger RE, Loda M, Stork PJ 1994 The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells. Mol Endocrinol 8:1289-1297
17. Buscail L, Delesque N, Esteve JP, Saint-Laurent N, Prats H, Clerc P, Robberecht P, Bell GI, Liebow C, Schally AV, Vaysse N, Susini C 1994 Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc Natl Acad Sci USA 91:2315-2319
18. Srikant CB, Shen SH 1996 Octapeptide somatostatin analog SMS 201-995 induces translocation of intracellular PTP1C to membranes in MCF-7 human breast adenocarcinoma cells. Endocrinology 137:3461-3468
19. Florio T, Thellung S, Arena S, Corsaro A, Bajetto A, Schettini G, Stork PJ 2000 Somatostatin receptor 1 (SSTR1)-mediated inhibition of cell proliferation correlates with the activation of the MAP kinase cascade: role of the phosphotyrosine phosphatase SHP-2. J Physiol Paris 94:239-250
20. Neel BG 1993 Structure and function of SH2-domain containing tyrosine phosphatases. Semin Cell Biol 4:419-432
21. Duan HF, Qu CK, Zhang QW, Yu WM, Wang H, Wu CT, Wang LS 2006 Shp-2 tyrosine phosphatase is required for hepatocyte growth factor-induced activation of sphingosine kinase and migration in embryonic fibroblasts. Cell Signal 27:27
22. Florio T, Yao H, Carey KD, Dillon TJ, Stork PJ 1999 Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1). Mol Endocrinol 13:24-37
23. Marrero MB, Venema VJ, Ju H, Eaton DC, Venema RC 1998 Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2. Am J Physiol 275:C1216-C1223
24. Pages P, Benali N, Saint-Laurent N, Esteve JP, Schally AV, Tkaczuk J, Vaysse N, Susini C, Buscail L 1999 sst2 somatostatin receptor mediates cell cycle arrest and induction of p27(Kip1). Evidence for the role of SHP-1. J Biol Chem 274:15186-15193
25. Lopez F, Ferjoux G, Cordelier P, Saint-Laurent N, Esteve JP, Vaysse N, Buscail L, Susini C 2001 Neuronal nitric oxide synthase: a substrate for SHP-1 involved in sst2 somatostatin receptor growth inhibitory signaling. FASEB J 15:2300-2302
26. D'Alessio A, Califano D, Incoronato M, Santelli G, Florio T, Schettini G, Carlomagno MS, Cerchia L, de Franciscis V 2003 The tyrosine phosphatase Shp-2 mediates intracellular signaling initiated by Ret mutants. Endocrinology 144:4298-4305
27. Tamir I, Dal Porto JM, Cambier JC 2000 Cytoplasmic protein tyrosine phosphatases SHP-1 and SHP-2: regulators of B cell signal transduction. Curr Opin Immunol 12:307-315
28. Fujioka Y, Matozaki T, Noguchi T, Iwamatsu A, Yamao T, Takahashi N, Tsuda M, Takada T, Kasuga M 1996 A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain-containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion. Mol Cell Biol 16:6887-6899
29. Ali S 2000 Recruitment of the protein-tyrosine phosphatase SHP-2 to the C-terminal tyrosine of the prolactin receptor and to the adaptor protein Gab2. J Biol Chem 275:39073-39080
30. Bennett AM, Hausdorff SF, O'Reilly AM, Freeman RM, Neel BG 1996 Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression. Mol Cell Biol 16:1189-1202
31. Meng TC, Fukada T, Tonks NK 2002 Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 9:387-399
32. Wang N, Li Z, Ding R, Frank GD, Senbonmatsu T, Landon EJ, Inagami T, Zhao ZJ 2006 Antagonism or synergism: role of tyrosine phosphatases shp-1 and shp-2 in growth factor signaling. J Biol Chem 281:21878-21883
33. Lopez F, Esteve JP, Buscail L, Delesque N, Saint-Laurent N, Theveniau M, Nahmias C, Vaysse N, Susini C 1997 The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling. J Biol Chem 272:24448-24454
34. Florio T, Arena S, Thellung S, Iuliano R, Corsaro A, Massa A, Pattarozzi A, Bajetto A, Trapasso F, Fusco A, Schettini G 2001 The activation of the phosphotyrosine phosphatase η (r-PTPη) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation. Mol Endocrinol 15:1838-1852
35. Zhang L, Martelli ML, Battaglia C, Trapasso F, Tramontano D, Viglietto G, Porcellini A, Santoro M, Fusco A 1997 Thyroid cell transformation inhibits the expression of a novel rat protein tyrosine phosphatase. Exp Cell Res 235:62-70
36. Borges LG, Seifert RA, Grant FJ, Hart CE, Disteche CM, Edelhoff S, Solca FF, Lieberman MA, Lindner V, Fischer EH, Lok S, Bowen-Pope DF 1996 Cloning and characterization of rat density-enhanced phosphatase-1, a protein tyrosine phosphatase expressed by vascular cells. Circ Res 79:570-580
37. Osborne JM, den Elzen N, Lichanska AM, Costelloe EO, Yamada T, Cassady AI, Hume DA 1998 Murine DEP-1, a receptor protein tyrosine phosphatase, is expressed in macrophages and is regulated by CSF-1 and LPS. J Leukoc Biol 64:692-701
38. Keane MM, Lowrey GA, Ettenberg SA, Dayton MA, Lipkowitz S 1996 The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells. Cancer Res 56:4236-4243
39. Iuliano R, Trapasso F, Le Pera I, Schepis F, Sama I, Clodomiro A, Dumon KR, Santoro M, Chiariotti L, Viglietto G, Fusco A 2003 An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo. Cancer Res 63:882-886
40. Martelli ML, Trapasso F, Bruni P, Berlingieri MT, Battaglia C, Vento MT, Belletti B, Iuliano R, Santoro M, Viglietto G, Fusco A 1998 Protein tyrosine phosphatase-η expression is upregulated by the PKA-dependent and is downregulated by the PKC-dependent pathways in thyroid cells. Exp Cell Res 245:195-202
41. Florio T, Scorziello A, Thellung S, Salzano S, Berlingieri MT, Fusco A, Schettini G 1997 Oncogene transformation of PC Cl3 clonal thyroid cell line induces an autonomous pattern of proliferation that correlates with a loss of basal and stimulated phosphotyrosine phosphatase activity. Endocrinology 138:3756-3763
42. Trapasso F, Iuliano R, Boccia A, Stella A, Visconti R, Bruni P, Baldassarre G, Santoro M, Viglietto G, Fusco A 2000 Rat protein tyrosine phosphatase η suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1). Mol Cell Biol 20:9236-9246
43. Massa A, Barbieri F, Aiello C, Arena S, Pattarozzi A, Pirani P, Corsaro A, Iuliano R, Fusco A, Zona G, Spaziante R, Florio T, Schettini G 2004 The expression of the phosphotyrosine phosphatase DEP-1/PTPη dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferation. J Biol Chem 279:29004-29012
44. Massa A, Barbieri F, Aiello C, Iuliano R, Arena S, Pattarozzi A, Corsaro A, Villa V, Fusco A, Zona G, Spaziante R, Schettini G, Florio T 2004 The phosphotyrosine phosphatase PTPη mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2. Ann NY Acad Sci 1030:264-274
45. Hershberger RE, Newman BL, Florio T, Bunzow J, Civelli O, Li XJ, Forte M, Stork PJ 1994 The somatostatin receptors SSTR1 and SSTR2 are coupled to inhibition of adenylyl cyclase in Chinese hamster ovary cells via pertussis toxin-sensitive pathways. Endocrinology 134:1277-1285
46. Ferjoux G, Lopez F, Esteve JP, Ferrand A, Vivier E, Vely F, Saint-Laurent N, Pradayrol L, Buscail L, Susini C 2003 Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and Inhibition of cell proliferation. Mol Biol Cell 14:3911-3928
47. Hortala M, Ferjoux G, Estival A, Bertrand C, Schulz S, Pradayrol L, Susini C, Clemente F 2003 Inhibitory role of the somatostatin receptor SST2 on the intracrine-regulated cell proliferation induced by the 210-amino acid fibroblast growth factor-2 isoform: implication of JAK2. J Biol Chem 278:20574-20581
48. Argetsinger LS, Carter-Su C 1996 Mechanism of signaling by growth hormone receptor. Physiol Rev 76:1089-1107
49. Roy B, Cathcart MK 1998 Induction of 15-lipoxygenase expression by IL-13 requires tyrosine phosphorylation of Jak2 and Tyk2 in human monocytes. J Biol Chem 273:32023-32029
50. Pelletier S, Duhamel F, Coulombe P, Popoff MR, Meloche S 2003 Rho family GTPases are required for activation of Jak/STAT signaling by G protein-coupled receptors. Mol Cell Biol 23:1316-1333
51. Hou SX, Zheng Z, Chen X, Perrimon N 2002 The Jak/STAT pathway in model organisms: emerging roles in cell movement. Dev Cell 3:765-778
52. Yin T, Shen R, Feng GS, Yang YC 1997 Molecular characterization of specific interactions between SHP-2 phosphatase and JAK tyrosine kinases. J Biol Chem 272:1032-1037
53. Dikic I, Tokiwa G, Lev S, Courtneidge SA, Schlessinger J 1996 A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 383:547-550
54. Ma YC, Huang J, Ali S, Lowry W, Huang XY 2000 Src tyrosine kinase is a novel direct effector of G proteins. Cell 102:635-646
55. Lu W, Gong D, Bar-Sagi D, Cole PA 2001 Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling. Mol Cell 8:759-769
56. Schettini G, Florio T, Meucci O, Landolfi E, Grimaldi M, Ventra C, Marino A 1989 Somatostatin inhibition of adenylate cyclase activity in different brain areas. Brain Res 492:65-71
57. Arena S, Pattarozzi A, Corsaro A, Schettini G, Florio T 2005 Somatostatin receptor subtype-dependent regulation of nitric oxide release: involvement of different intracellular pathways. Mol Endocrinol 19:255-267
58. Somani AK, Bignon JS, Mills GB, Siminovitch KA, Branch DR 1997 Src kinase activity is regulated by the SHP-1 protein-tyrosine phosphatase. J Biol Chem 272:21113-21119
59. Kong M, Mounier C, Dumas V, Posner BI 2003 Epidermal growth factor-induced DNA synthesis. Key role for Src phosphorylation of the docking protein Gab2. J Biol Chem 278:5837-5844
60. Ren Y, Meng S, Mei L, Zhao ZJ, Jove R, Wu J 2004 Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor. J Biol Chem 279:8497-8505
61. Zhang SQ, Yang W, Kontaridis MI, Bivona TG, Wen G, Araki T, Luo J, Thompson JA, Schraven BL, Philips MR, Neel BG 2004 Shp2 regulates SRC family kinase activity and Ras/Erk activation by controlling Csk recruitment. Mol Cell 13:341-355
62. Roskoski Jr R 2005 Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Commun 331:1-14
63. Wu DW, Stark KC, Dunnington D, Dillon SB, Yi T, Jones C, Pelus LM 2000 SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells. Blood Cells Mol Dis 26:15-24
64. Amiri F, Venema VJ, Wang X, Ju H, Venema RC, Marrero MB 1999 Hyperglycemia enhances angiotensin II-induced janus-activated kinase/STAT signaling in vascular smooth muscle cells. J Biol Chem 274:32382-32386
65. Wong M, Uddin S, Majchrzak B, Huynh T, Proudfoot AE, Platanias LC, Fish EN 2001 Rantes activates Jak2 and Jak3 to regulate engagement of multiple signaling pathways in T cells. J Biol Chem 276:11427-11431
66. Sugimoto S, Wandless T, Shoelson S, Neel B, Walsh C 1994 Activation of the SH2-containing protein tyrosine phosphatase, SH-PTP2, by phosphotyrosine-containing peptides derived from insulin receptor substrate-1. J Biol Chem 269:13614-13622
67. Imhof D, Wavreille AS, May A, Zacharias M, Tridandapani S, Pei D 2006 Sequence specificity of SHP-1 and SHP-2 Src homology 2 domains. Critical roles of residues beyond the pY+3 position. J Biol Chem 281:20271-20282
68. Schmitt JM, Stork PJ 2001 Cyclic AMP-mediated inhibition of cell growth requires the small G protein Rap1. Mol Cell Biol 21:3671-3683
69. Pero SC, Oligino L, Daly RJ, Soden AL, Liu C, Roller PP, Li P, Krag DN 2002 Identification of novel non-phosphorylated ligands, which bind selectively to the SH2 domain of Grb7. J Biol Chem 277:11918-11926
70. Stoker AW 2005 Protein tyrosine phosphatases and signalling. J Endocrinol 185:19-33
71. Jandt E, Denner K, Kovalenko M, Ostman A, Bohmer FD 2003 The protein-tyrosine phosphatase DEP-1 modulates growth factor-stimulated cell migration and cellmatrix adhesion. Oncogene 22:4175-4185
72. Le Pera I, Iuliano R, Florio T, Susini C, Trapasso F, Santoro M, Chiariotti L, Schettini G, Viglietto G, Fusco A 2005 The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue. Oncogene 24:3187-3195
73. Kovalenko M, Denner K, Sandstrom J, Persson C, Gross S, Jandt E, Vilella R, Bohmer F, Ostman A 2000 Site-selective dephosphorylation of the platelet-derived growth factor β-receptor by the receptor-like protein-tyrosine phosphatase DEP-1. J Biol Chem 275:16219-16226
74. Palka HL, Park M, Tonks NK 2003 Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1. J Biol Chem 278:5728-5735
75. Dunphy WG, Kumagai A 1991 The cdc25 protein contains an intrinsic phosphatase activity. Cell 67:189-196
76. Corsaro A, Thellung S, Russo C, Villa V, Arena S, D'Adamo MC, Paludi D, Rossi Principe D, Damonte G, Benatti U, Aceto A, Tagliavini F, Schettini G, Florio T 2002 Expression in E. coli and purification of recombinant fragments of wild type and mutant human prion protein. Neurochem Int 41:55-63